New Panel for Trial Drugs Raises Hopes for the Terminally Ill
Johnson and Johnson will create an independent group of doctors, patient advocates and ethicist to evaluate trial drugs for terminally ill patients seeking treatment for their diseases.
( Getty )
( Getty )
